GENE ONLINE|News &
Opinion
Blog

GeneOnline

WRITTEN BY GeneOnline

Laekna Therapeutics Announces Dosing of First Patients in the U.S. and China in Phase Ib/III Study of Afuresertib in Combination with Fulvestrant in HR+/HER2- Breast Cancer
2022-05-26
Servier Announces FDA Approval of TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine for Patients with Newly Diagnosed IDH1-mutated Acute Myeloid Leukemia
2022-05-25
Travecta Therapeutics Announces In-Person Presentation at 2022 BIO International Convention
2022-05-24
Medison Pharma Announces Extension of Multi-territorial Agreement with Immunocore and Expansion into Australia and New Zealand
2022-05-23
The First International Biomedical Entrepreneurship Competition Has Announced Its Top 6 Winners
2022-05-23
Clinical trial results of Belief BioMed’s hemophilia B gene therapy drug candidate BBM-H901 published in The Lancet Haematology
2022-05-19
CanSinoBIO’s COVID-19 Vaccine Convidecia™ Receives WHO Emergency Use Listing
2022-05-19
FDA Allows Resumption of Gilead’s Lenacapavir AIDS Trials
2022-05-19
PostEra spearheads AI-driven drug discovery collaboration to develop antiviral therapeutics with initial $68M in NIH funding
2022-05-18
P&G Health dons the Purple Ribbon to commemorate Neuropathy Awareness Week
2022-05-17
New Kind of Cell Division Without DNA Replication
2022-05-12
Cowpea Mosaic Virus Sheds Light on Cancer Therapy
2022-05-11
Leading HealthTech AI company NuraLogix announces new partnership with LaFiya TeleHealth
2022-05-05
First Patient Dosed in Phase II Renal Cancer Theranostics Study
2022-05-04
The Danish National Genome Center Partners with Lifebit to Deliver Nationwide Personalised Medicine
2022-04-28
1 2 3 28
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!